Sagimet Biosciences (NASDAQ:SGMT – Free Report) had its target price lifted by Canaccord Genuity Group from $49.00 to $56.00 in a research note released on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently weighed in on SGMT. Guggenheim decreased their price target on Sagimet [...]
Sagimet Biosciences (NASDAQ:SGMT) Price Target Raised to $56.00
Source: Ticker Report
Read Full Story →
